Advertisement

Merial Company Profile

12:45 EDT 19th May 2013 | BioPortfolio

Merial is a world-leading, innovation-driven animal health company that provides a comprehensive range of products to enhance the health, well-being and performance of a wide range of animals. Merial employs approximately 5,600 people and operates in more than 150 countries worldwide. Its 2010 sales were more than $2.6 billion. Merial is a Sanofi company.


News Articles [ 20 Associated News Articles listed on BioPortfolio]

Pet Owners Share Stories about Importance of Vaccinations

DULUTH, Ga., Sept. 17, 2012 /PRNewswire/ -- Vaccinations are the cornerstone of a long, happy life for cats and dogs. To help reinforce the importance of regular veterinary visits and vaccination...

DSM and Merial to Explore the Use of DSM's Algal Expression System for Animal Vaccine Development

COLUMBIA, Md., Oct. 10, 2012 /PRNewswire/ -- DSM Nutritional Products, a subsidiary of Royal DSM, the global Life Sciences and Materials Sciences company, announced today that it has entered into...

UPDATE 1-Sanofi to expand animal health business in India

* No financial details given (Adds details, background, Merial CEO comment)

VitamFero/Merial : les bases d’une alliance de long terme

Le compte à rebours est lancé. La biotech francilienne et tourangelle VitamFero, qui développe des vaccins vétérinaires…

CORRECTED-India's Cipla loses PetArmor case in U.S. appeals court

(Corrects paragraphs 2 and 3 to say that PetArmor is owned by FidoPharm, not Merial. Also fixes judgment date in paragraph 3)

Genetic Technologies Provides U.S. Patent Re-Examination Update

MELBOURNE, AUSTRALIA -- (Marketwire) -- 03/15/13 -- Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) is pleased to announce that the United States Patent and Trademark Office ("USPTO") has now...

Cipla Loses Higher Court Ruling Over Sanofi Pet Drug Infringement

A U.S. appeals court has upheld a judgment declaring Cipla infringed a U.S. patent for a veterinary drug produced for Sanofi unit, Merial.

News and press releases: Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 5-7 March 2013

The Committee adopted by consensus a positive opinion for an initial marketing authorisation application for Oncept IL-2 from MERIAL an immunotherapy product to be used in addition to surgery and radi...

Drugs and Medications [0 Results]

None

PubMed Articles [ 11 Associated PubMed Articles listed on BioPortfolio]

Endoparasites of cats from the Tirana area and the first report on Aelurostrongylus abstrusus (Railliet, 1898) in Albania.

Following the recovery of first-stage nematode larvae indicative of Aelurostrongylus abstrusus infection in the faeces of free-roaming cats from the greater Tirana area, examination of 18 cats at necr...

Synergy between fipronil and amitraz in a Rhipicephalus sanguineus tick residual contact test.

Amitraz, a formamidine acaricide, has been reported to act as a synergist of contact insecticides and acaricides in both agriculture and animal health. A laboratory contact test was therefore conducte...

Three-year duration of immunity in cats vaccinated with a canarypox-vectored recombinant rabies virus vaccine.

Despite the availability of efficacious vaccines for animals and humans, rabies is still a major zoonosis. Prevention of rabies in dogs and cats is key for reducing the risk of transmission of this de...

An African horse sickness virus serotype 4 recombinant canarypox virus vaccine elicits specific cell-mediated immune responses in horses.

A recombinant canarypox virus vectored vaccine co-expressing synthetic genes encoding outer capsid proteins, VP2 and VP5, of African horse sickness virus (AHSV) serotype 4 (ALVAC(®)-AHSV4) has been d...

Defining the concept of 'tick repellency' in veterinary medicine.

SUMMARYAlthough widely used, the term repellency needs to be employed with care when applied to ticks and other periodic or permanent ectoparasites. Repellency has classically been used to describe th...

Clinical Trials [0 Results]

None

Companies [ 4 Associated Companies listed on BioPortfolio]

Merial

Merial is a world-leading, innovation-driven animal health company that provides a comprehensive range of products to enhance the health, well-being and performance of a wide rang...

MERIAL Limited

Merial is a world-leading animal health company. We are a forward-looking company with a proven track record, producing pharmaceutical products and vaccines for livestock, pets and wildlife. We are on...

The CATalyst Council

The 2009 CATalyst Council board of directors includes: Dr. Jane E. Brunt as executive director; Dan Kramer, senior marketing manager of industry relations, Pfizer Animal Health, as chair; Robert Rohde...

Aventis

Aventis is dedicated to improving life through the discovery and development of innovative pharmaceutical products. We offer a range of patented prescription drugs to treat patients with serious disea...

More Information about "Merial" on BioPortfolio

We have published hundreds of Merial news stories on BioPortfolio along with dozens of Merial Clinical Trials and PubMed Articles about Merial for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Merial Companies in our database. You can also find out about relevant Merial Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement